Sotorasib versus docetaxel: evidence supporting CodeBreaK 200 von Paz-Ares, Luis, Mehta, Bhakti, Wang, Yang, Waterhouse, David, de Langen, Adrianus Johannes

Volltext

Association of tumour and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with DCB and OS to nivolumab treatment in NSCLC patients pre-treated with chemotherapy von Niemeijer, Anna-Larissa Nadia, Sahba, Sara, Smit, Egbert Frederik, Lissenberg-Witte, Birgit Ilja, de Langen, Adrianus Johannes, Thunnissen, Erik

Volltext

A reply to “Comment on: ‘Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer” von van Veggel, Bianca, de Langen, Adrianus Johannes

Volltext

Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients von Kramer, Gerbrand Maria, Frings, Virginie, Hoetjes, Nikie, Hoekstra, Otto S, Smit, Egbert F, de Langen, Adrianus Johannes, Boellaard, Ronald

Volltext

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial von de Langen, Adrianus Johannes, Johnson, Melissa L, Mazieres, Julien, Dingemans, Anne-Marie C, Mountzios, Giannis, Pless, Miklos, Wolf, Jürgen, Schuler, Martin, Lena, Hervé, Skoulidis, Ferdinandos, Yoneshima, Yasuto, Kim, Sang-We, Linardou, Helena, Novello, Silvia, van der Wekken, Anthonie J, Chen, Yuanbin, Peters, Solange, Felip, Enriqueta, Solomon, Benjamin J, Ramalingam, Suresh S., Dooms, Christophe, Lindsay, Colin R, Ferreira, Carlos Gil, Blais, Normand, Obiozor, Cynthia C, Wang, Yang, Mehta, Bhakti, Varrieur, Tracy, Ngarmchamnanrith, Gataree, Stollenwerk, Björn, Waterhouse, David, Paz-Ares, Luis

Volltext

Sotorasib in KRASG12C mutated lung cancer – Authors' reply von Paz-Ares, Luis, Mehta, Bhakti, Wang, Yang, Obiozor, Cynthia, Waterhouse, David, de Langen, Adrianus Johannes

Volltext

Sotorasib in KRAS G12C mutated lung cancer - Authors' reply von Paz-Ares, Luis, Mehta, Bhakti, Wang, Yang, Obiozor, Cynthia, Waterhouse, David, de Langen, Adrianus Johannes

Volltext

PPD01.02 Repotrectinib in Patients With ROS1 Fusion-Positive (ROS1+) NSCLC: Update From the Pivotal Phase 1/2 TRIDENT-1 Trial von Drilon, Alexander, Camidge, D. Ross, Lin, Jessica J., Kim, Sang-We, Solomon, Benjamin, Dziadziuszko, Rafal, Besse, Benjamin, Goto, Koichi, Johannes de Langen, Adrianus, Wolf, Jürgen, Lee, Ki Hyeong, Popat, Sanjay, Springfeld, Christoph, Nagasaka, Misako, Felip, Enriqueta, Yang, Nong, Lu, Shun, Kao, Steven, Velcheti, Vamsidhar, Cheema, Parneet, Stopatschinskaja, Shanna, Mehta, Minal, Trone, Denise, Ades, Felipe, Calvet, Christophe Y., Cho, Byoung Chul

Volltext

Trastuzumab Deruxtecan in Patients With HER2 -Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial von Goto, Koichi, Goto, Yasushi, Kubo, Toshio, Ninomiya, Kiichiro, Kim, Sang-We, Planchard, David, Ahn, Myung-Ju, Smit, Egbert F, de Langen, Adrianus Johannes, Pérol, Maurice, Pons-Tostivint, Elvire, Novello, Silvia, Hayashi, Hidetoshi, Shimizu, Junichi, Kim, Dong-Wan, Kuo, Chih-Hsi, Yang, James Chih-Hsin, Pereira, Kaline, Cheng, Fu-Chih, Taguchi, Ayumi, Cheng, Yingkai, Feng, Wenqin, Tsuchihashi, Zenta, Jänne, Pasi A

Volltext

18F-FDG PET/CT to predict tumor PD-L1 expression and response to PD-(L)1 blockade in patients with non-small-cell lung cancer von Borm, Frank Johannes, De Langen, Adrianus Johannes

Volltext

Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer von Drilon, Alexander, Camidge, D. Ross, Lin, Jessica J., Kim, Sang-We, Solomon, Benjamin J., Dziadziuszko, Rafal, Besse, Benjamin, Goto, Koichi, de Langen, Adrianus Johannes, Wolf, Jürgen, Lee, Ki Hyeong, Popat, Sanjay, Springfeld, Christoph, Nagasaka, Misako, Felip, Enriqueta, Yang, Nong, Velcheti, Vamsidhar, Lu, Shun, Kao, Steven, Dooms, Christophe, Krebs, Matthew G., Yao, Wenxiu, Beg, Muhammad Shaalan, Hu, Xiufeng, Moro-Sibilot, Denis, Cheema, Parneet, Stopatschinskaja, Shanna, Mehta, Minal, Trone, Denise, Graber, Armin, Sims, Gregory, Yuan, Yong, Cho, Byoung Chul

Volltext

Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With... von Qi, Zhenhao, Ha, Thomas, Feng, Wenqin, Karnoub, Maha, Pereira, Kaline, Shiga, Ryota, Smit, Egbert F, Goto, Yasushi, De Langen, Adrianus Johannes, Goto, Koichi, Velasco Roth, Anne Marie, Khambata-Ford, Shirin

Volltext

Centralization of lung cancer surgery in the Netherlands: differences in care and survival of patients with stage I non-small cell lung cancer between hospitals with and without in... von de Ruiter, Julianne Cynthia, Heineman, David Jonathan, de Langen, Adrianus Johannes, Dahele, Max, Damhuis, Ronald Alphons Maria, Hartemink, Koen Johan

Volltext

Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer 18 F-FDG PET Radiomics von Kolinger, Guilherme D, García, David Vállez, Kramer, Gerbrand Maria, Frings, Virginie, Zwezerijnen, Gerben J C, Smit, Egbert F, de Langen, Adrianus Johannes, Buvat, Irène, Boellaard, Ronald

Volltext

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer von Drilon, Alexander, Camidge, D. Ross, Lin, Jessica J, Kim, Sang-We, Solomon, Benjamin J, Dziadziuszko, Rafal, Besse, Benjamin, Goto, Koichi, de Langen, Adrianus Johannes, Wolf, Juergen, Lee, Ki Hyeong, Popat, Sanjay, Springfeld, Christoph, Nagasaka, Misako, Felip, Enriqueta, Yang, Nong, Velcheti, Vamsidhar, Lu, Shun, Kao, Steven, Dooms, Christophe, Krebs, Matthew G, Yao, Wenxiu, Beg, Muhammad Shaalan, Hu, Xiufeng, Moro-Sibilot, Denis, Cheema, Parneet, Stopatschinskaja, Shanna, Mehta, Minal, Trone, Denise, Graber, Armin, Sims, Gregory, Yuan, Yong, Cho, Byoung Chul

Volltext

Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer von Drilon, Alexander, Camidge, D. Ross, Lin, Jessica J, Kim, Sang-We, Solomon, Benjamin J, Dziadziuszko, Rafal, Besse, Benjamin, Goto, Koichi, de Langen, Adrianus Johannes, Wolf, Jürgen, Lee, Ki Hyeong, Popat, Sanjay, Springfeld, Christoph, Nagasaka, Misako, Felip, Enriqueta, Yang, Nong, Velcheti, Vamsidhar, Lu, Shun, Kao, Steven, Dooms, Christophe, Krebs, Matthew G, Yao, Wenxiu, Beg, Muhammad Shaalan, Hu, Xiufeng, Moro-Sibilot, Denis, Cheema, Parneet, Stopatschinskaja, Shanna, Mehta, Minal, Trone, Denise, Graber, Armin, Sims, Gregory, Yuan, Yong, Cho, Byoung Chul

Volltext

Sotorasib versus docetaxel for previously treated non-small- cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial von de Langen, Adrianus Johannes, Johnson, Melissa L, Mazieres, Julien, Dingemans, Anne-Marie C, Mountzios, Giannis, Pless, Miklos, Wolf, Jurgen, Schuler, Martin, Lena, Herve, Skoulidis, Ferdinandos, Yoneshima, Yasuto, Kim, Sang-We, Linardou, Helena, Novello, Silvia, van der Wekken, Anthonie J, Chen, Yuanbin, Peters, Solange, Felip, Enriqueta, Solomon, Benjamin J, Ramalingam, Suresh S, Dooms, Christophe, Lindsay, Colin R, Ferreira, Carlos Gil, Blais, Normand, Obiozor, Cynthia C, Wang, Yang, Mehta, Bhakti, Varrieur, Tracy, Ngarmchamnanrith, Gataree, Stollenwerk, Bjorn, Waterhouse, David, Paz-Ares, Luis

Volltext

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer 18F-FDG PET Radiomics von Kolinger, Guilherme D, García, David Vállez, Kramer, Gerbrand Maria, Frings, Virginie, Zwezerijnen, Gerben JC, Smit, Egbert F, de Langen, Adrianus Johannes, Buvat, Irène, Boellaard, Ronald

Volltext

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS G12C mutation: a randomised, open-label, phase 3 trial von de Langen, Adrianus Johannes, Johnson, Melissa L, Mazieres, Julien, Dingemans, Anne-Marie C, Mountzios, Giannis, Pless, Miklos, Wolf, Jürgen, Schuler, Martin, Lena, Hervé, Skoulidis, Ferdinandos, Yoneshima, Yasuto, Kim, Sang-We, Linardou, Helena, Novello, Silvia, van der Wekken, Anthonie J, Chen, Yuanbin, Peters, Solange, Felip, Enriqueta, Solomon, Benjamin J, Ramalingam, Suresh S, Dooms, Christophe, Lindsay, Colin R, Ferreira, Carlos Gil, Blais, Normand, Obiozor, Cynthia C, Wang, Yang, Mehta, Bhakti, Varrieur, Tracy, Ngarmchamnanrith, Gataree, Stollenwerk, Björn, Waterhouse, David, Paz-Ares, Luis

Volltext

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program von Illini, Oliver, Hochmair, Maximilian Johannes, Fabikan, Hannah, Weinlinger, Christoph, Tufman, Amanda, Swalduz, Aurélie, Lamberg, Kristina, Hashemi, Sayed M. S., Huemer, Florian, Vikström, Anders, Wermke, Martin, Absenger, Gudrun, Addeo, Alfredo, Banerji, Shantanu, Calles, Antonio, Clarke, Stephen, Di Maio, Massimo, Durand, Alice, Duruisseaux, Michaël, Itchins, Malinda, Kääränien, Okko-Sakari, Krenn, Florian, Laack, Eckart, de Langen, Adrianus Johannes, Mohorcic, Katja, Pall, Georg, Passaro, Antonio, Prager, Gerald, Rittmeyer, Achim, Rothenstein, Jeffrey, Schumacher, Michael, Wöll, Ewald, Valipour, Arschang

Volltext